(0.29%) 5 169.50 points
(0.23%) 38 922 points
(0.27%) 18 050 points
(1.04%) $78.92
(0.61%) $2.16
(0.86%) $2 328.40
(2.73%) $27.42
(1.11%) $976.05
(-0.01%) $0.929
(-0.25%) $10.85
(-0.24%) $0.795
(0.01%) $91.46
3 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 7.41%
@ $9.99
发出时间: 14 Feb 2024 @ 22:33
回报率: -7.61%
上一信号: Feb 13 - 22:38
上一信号:
回报率: -0.10 %
Live Chart Being Loaded With Signals
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients...
Stats | |
---|---|
今日成交量 | 71 279.00 |
平均成交量 | 138 068 |
市值 | 250.13M |
EPS | $0 ( 2024-03-21 ) |
下一个收益日期 | ( $-0.0400 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -15.38 |
ATR14 | $0.0260 (0.28%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | Andrade Robert | Buy | 1 042 | Common shares |
2024-04-30 | Raykov Rosty | Buy | 2 431 | Common shares |
2024-05-01 | Raykov Rosty | Sell | 2 431 | Common shares |
2024-04-18 | Haigh Adrian | Buy | 22 222 | Common Shares |
2024-04-17 | Haigh Adrian | Buy | 22 222 | Common Shares |
INSIDER POWER |
---|
8.47 |
Last 100 transactions |
Buy: 1 356 995 | Sell: 926 579 |
音量 相关性
Fennec Pharmaceuticals 相关性 - 货币/商品
Fennec Pharmaceuticals 财务报表
Annual | 2023 |
营收: | $21.64M |
毛利润: | $20.36M (94.08 %) |
EPS: | $-0.610 |
FY | 2023 |
营收: | $21.64M |
毛利润: | $20.36M (94.08 %) |
EPS: | $-0.610 |
FY | 2022 |
营收: | $1.54M |
毛利润: | $1.45M (94.40 %) |
EPS: | $-0.950 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.667 |
Financial Reports:
No articles found.
Fennec Pharmaceuticals
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。